Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome

Pediatric Nephrology

Volumn 19, Issue 3, 2004, Pages 281-287

  Loeffler, Kim ^a   Gowrishankar, Manjula ^a   Yiu, Verna ^a,b  

^a UNIVERSITY OF ALBERTA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Adverse events; Efficacy; Focal segmental glomerulosclerosis; Tacrolimus; Treatment

Indexed keywords

ALKYLATING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; LEVAMISOLE; METHYLPREDNISOLONE; MINOXIDIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS;

ACUTE KIDNEY FAILURE; ADOLESCENT; ADULT; ANEMIA; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC TEST; DISEASE EXACERBATION; DISEASE RESISTANCE; DOSE RESPONSE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; FOCAL GLOMERULONEPHRITIS; FOLLOW UP; GINGIVA HYPERPLASIA; GRAND MAL SEIZURE; HUMAN; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; MALE; MINIMAL CHANGE GLOMERULONEPHRITIS; NEPHROSIS; NEPHROTIC SYNDROME; PRIORITY JOURNAL; RELAPSE; REMISSION; RETROSPECTIVE STUDY; SEIZURE; SEPSIS;

ADOLESCENT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIHYPERTENSIVE AGENTS; CHILD; CHILD, PRESCHOOL; DRUG RESISTANCE; FEMALE; GLUCOCORTICOIDS; HUMANS; HYPERTENSION, RENAL; IMMUNOSUPPRESSIVE AGENTS; MALE; MYCOPHENOLIC ACID; NEPHROTIC SYNDROME; PREDNISONE; RETROSPECTIVE STUDIES; TACROLIMUS; TREATMENT OUTCOME;

EID: 1542269808     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-003-1370-3     Document Type: Article

References (37)

1. McEnery PT, Alexander SR, Sullican K, Tejani A (1993) Renal transplantation in children and adolescents: the 1992 Annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 7:711-720
2. Southwest Pediatric Nephrology Group (1985) Focal segmental glomerulosclerosis in children with idiopathic nephrotic syndrome. Kidney Int 27:442-449
3. North American Pediatric Renal Transplant Cooperative Study (NAPRTCS) (2002) Annual report. Pediatr Nephrol (in press)
4. Warady BA, Hebet D, Sullivan KE, Alexander SR, Tejani A (1997) Renal transplantation, chronic dialysis, and chronic renal insufficiency in children and adolescents. The 1995 annual report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 11:49-64
5. Srivastava T, Simon S, Alon U (1999) High incidence of focal segmental glomerulosclerosis in nephrotic syndrome in childhood. Pediatr Nephrol 13:13-18
6. Waldo FB, Benfield MR, Kohaut EC (1998) Therapy of focal and segmental glomerulosclerosis with methylprednisolone, cyclosporine A, and prednisone. Pediatr Nephrol 12:397-400
7. Singh A, Tejani C, Tejani A (1999) One-centre experience with cyclosporin in refractory nephrotic syndrome in children. Pediatr Nephrol 13:26-32
8. Franke D, Zimmering M, Wolfish N, Ehrich J, Filler G (2000) Treatment of FSGS with plasma exchange and immunadsorption. Pediatr Nephrol 14:965-969
9. Tune B, Lieberman E, Mendoza S (1996) Steroid-resistant nephrotic focal segmental glomerulosclerosis: a treatable disease. Pediatr Nephrol 10:772-778
10. Burgess E (1999) Management of focal segmental glomerulosclerosis: evidence based recommendations. Kidney Int 55:S26-S32
11. Arbus GS, Poucell S, Bacheyie GS, Baumal R (1982) Focal segmental glomerulosclerosis with idiopathic nephrotic syndrome: three types of clinical response. J Pediatr 101:40-45
12. Banfi G, Moriggi M, Sabadini E, Fellini G, D'Amico G, Ponticelli C (1991) The impact of prolonged immunosuppression on the outcome of idiopathic focal segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study. Clin Nephrol 36:53-59
13. Waldo FB, Kohaut EC (1987) Therapy of focal segmental glomerulosclerosis with cyclosporine A. Pediatr Nephrol 1:180-182
14. Haas M, Godfrin Y, Oberbauer R, Yilmaz N, Borchhardt K, Regele H, Druml W, Derfler K, Mayer G (1998) Plasma immunoadsorption treatment in patients with primary focal segmental glomerulosclerosis. Nephrol Dial Transplant 13: 2013-2016
15. Aviles DH, Irwin KC, Dublin LX, Vehaskari VM (1999) Aggressive treatment of severe idiopathic focal segmental glomerulosclerosis. Pediatr Nephrol 13:298-300
16. Mitwalli AH (1998) Adding plasmapheresis to corticosteroids and alkylating agents: does it benefit patients with focal segmental glomerulosclerosis? Nephrol Dial Transplant 13: 1524-1528
17. Tarshich P, Tokin JN, Remstein J, Edelmann CM Jr (1996) Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosis: a report of the International Study of Kidney Disease in Children. Pediatr Nephrol 10:590-593
18. Geary DF, Farnie M, Thourer P, Baumal R (1984) Response to cyclophosphamide in steroid resistant focal segmental glomerulosclerosis: a reappraisal. Clin Nephrol 22:109-113
19. Barletta GM, Smoyer WE, Bunchman TE, Flynn JT, Kershaw DB (2003) Use of mycophenolate mofetil in steroid-dependent and resistant nephrotic syndrome. Pediatr Nephrol 18:833-837
20. Beaufils H, Alphonse J, Guedon J, Legrain M (1978) Focal segmental glomerulosclerosis: natural history and treatment. Nephron 21:75-81
21. Cameron JS, Turner DR, Ogg CS, Chantler C, Williams DG (1978) The long-term prognosis of patients with focal segmental glomerulosclerosis. Clin Nephrol 10:213-218
22. Korbet SM, Schwartz MM, Lewis EJ (1994) Primary focal segmental glomerulosclerosis: clinical course and response to therapy. Am J Kidney Dis 23:773-783
23. Martinelli R, Okumura AS, Pereira LJ, Rocha H (2001) Primary focal segmental glomerulosclerosis in children: prognostic factors. Pediatr Nephrol 16:658-661
24. Denton MD, Magee CC, Sayegh MH (1999) Immunosuppressive strategies in transplantation. Lancet 353:1083-1091
25. McCauley J, Tzakis AG, Fung JJ, Todo S, Starzl TE (1990) FK 506 in steroid resistant focal sclerosing glomerulonephritis of childhood. Lancet 335:674
26. McCauley J, Shapiro R, Ellis D, Igdal H, TzakisA, Starzl TE (1993) Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome. Nephrol Dial Transplant 8:1286-1290
27. Schweda F, Liebl R, Riegger GAJ, Kramer BK (1997) Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome. Nephrol Dial Transplant 12:2433-2435
28. Segarra A, Vila J, Pou L, Majo J, Arbos A, Quiles T, Piera L (2002) Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up. Nephrol Dial Transplant 17:655-662
29. Pennesi M, Gagliardo A, Minisini S (2003) Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome. Pediatr Nephrol 18:477-478
30. Hogg RJ, Portman RJ, Milliner D, Lanley KV, Eddy A, Ingelfinger J (2000) Evaluation and management of proteinuria and nephrotic syndrome in children: recommendations from a pediatric nephrology panel established at the National Kidney Foundation conference on proteinuria, albuminuria, risk, assessment, detection, and elimination (PARADE). Pediatrics 105:1-16
31. Anonymous (1996) Update on the 1987 Task Force Report on High-blood Pressure in Children and Adolescents: a working group report from the National High Blood Pressure Education Program. Pediatrics 98:649-658
32. Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259-263
33. Wildin RS, Smyk-Pearson S, Filipovich AH (2002) Clinical and molecular features of the immunodysregulation, polyendocrinopathy, enteropathy, X-linked (IPEX) syndrome. J Med Genet 39:537-545
34. Budde K, Fritsche L, Neumayer H-H (1997) Differing proteinuria control with cyclosporine and tacrolimus. Lancet 349:330
35. Kessler M, Champigneulles J, Hestin D, Frimat L, Renoult E (1999) A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus. Transplantation 67:641-643
36. Maruyama K, Tomizawa S, Sekei Y, Arai H, Kuroume T (1992) Inhibition of vascular permeability factor production by cyclosporine in minimal change nephrotic syndrome. Nephron 62:27-30
37. Maruyama K, Tomizawa S, Sekei Y, Arai J, Ogawa T, Kuroume T (1994) FK506 for vascular permeability factor production in minimal change nephrotic syndrome. Nephron 66:486-487